Search - tctmd.com

Displaying 341 - 360 of 367

Sort: Relevancy | Date

Presentation TVT 2019

V-Wave for HFrEF and HFpEF

Presenter: Josep Rodés-Cabau

June 15, 2019

Presentation TVT 2019

Transcatheter Subannular Remodeling for HFrEF: Early ANCORA Experiences

Presenter: Mark Reisman

June 15, 2019

News Conference News ESC Heart Failure 2019

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

Shelley Wood

May 26, 2019

News Conference News HRS 2019

BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients

Todd Neale

May 15, 2019

News Daily News

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

L.A. McKeown

April 23, 2019

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

News Daily News

FDA Approves the Optimizer Smart Implantable Pulse Generator for Heart Failure

Yael L. Maxwell

March 22, 2019

News Daily News

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Shelley Wood

February 26, 2019

News Industry News

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

February 25, 2019

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

Presentation TCT Abstracts Posters 2018

Flourish: RT-100 Phase 3 Trial for HFrEF

Presenter: James Heywood

September 25, 2018

Presentation TCT 2018

Cardiac Contractility Modulation for HFrEF and HFmrEF

Presenter: James E. Udelson, Clyde W. Yancy, William T. Abraham

September 22, 2018

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

Presentation TCT 2016

Interatrial Shunts in HFrEF: Focus on V-Wave

Presenter: Josep Rodés-Cabau, Nir Uriel, William T. Abraham

November 01, 2016

Presentation TCT 2016

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

Presenter: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld, Ileana L. Pina

October 31, 2016

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Industry News

New CHAMPION Data Show Significant Improvement in Survival Rates for Heart Failure Patients with Reduced Ejection Fraction

March 15, 2015

Presentation TCT 2014

Decompressing the Left Atrium: V-Wave Interatrial Shunt Therapy for HFrEF

Presenter: Daniel Burkhoff, Mark Goldberger, Josep Rodés-Cabau

September 16, 2014

News Industry News

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

April 22, 2013

Advertisement

V-Wave for HFrEF and HFpEF

Transcatheter Subannular Remodeling for HFrEF: Early ANCORA Experiences

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

FDA Approves the Optimizer Smart Implantable Pulse Generator for Heart Failure

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

Flourish: RT-100 Phase 3 Trial for HFrEF

Cardiac Contractility Modulation for HFrEF and HFmrEF

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Interatrial Shunts in HFrEF: Focus on V-Wave

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

New CHAMPION Data Show Significant Improvement in Survival Rates for Heart Failure Patients with Reduced Ejection Fraction

Decompressing the Left Atrium: V-Wave Interatrial Shunt Therapy for HFrEF

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content